SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-023085
Filing Date
2023-08-10
Accepted
2023-08-10 16:24:56
Documents
60
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pirs20230607_10q.htm   iXBRL 10-Q 1251697
2 EXHIBIT 10.2 ex_555614.htm EX-10.2 50740
3 EXHIBIT 31.1 ex_531047.htm EX-31.1 8556
4 EXHIBIT 31.2 ex_531048.htm EX-31.2 9280
5 EXHIBIT 32.1 ex_531049.htm EX-32.1 4243
6 EXHIBIT 32.2 ex_531050.htm EX-32.2 4224
  Complete submission text file 0001437749-23-023085.txt   5562745

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA pirs-20230630.xsd EX-101.SCH 47291
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pirs-20230630_cal.xml EX-101.CAL 37360
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pirs-20230630_def.xml EX-101.DEF 311205
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20230630_lab.xml EX-101.LAB 283298
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20230630_pre.xml EX-101.PRE 333982
54 EXTRACTED XBRL INSTANCE DOCUMENT pirs20230607_10q_htm.xml XML 835585
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37471 | Film No.: 231159924
SIC: 2834 Pharmaceutical Preparations